<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:mp ids='MP_0002055'>Diabetes</z:mp> is a leading cause of morbidity and mortality </plain></SENT>
<SENT sid="1" pm="."><plain>The purpose of this study is to assess the associations between <z:mp ids='MP_0002055'>diabetes</z:mp> complications and mortality in the Early Treatment Diabetic <z:hpo ids='HP_0000488'>Retinopathy</z:hpo> Study (ETDRS) </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: We examined demographic, clinical, and laboratory characteristics of the 3,711 subjects enrolled in the ETDRS, a randomized controlled clinical trial designed to evaluate the role of laser photocoagulation and aspirin therapy for diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The outcome assessed was <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality </plain></SENT>
<SENT sid="4" pm="."><plain>Multivariable Cox proportional hazards regression was used to assess associations between <z:mp ids='MP_0002055'>diabetes</z:mp> complications and mortality for type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> separately </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The 5-year estimates of <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality were 5.5 and 18.9% for patients with type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>In patients with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:mpath ids='MPATH_686'>amputation</z:mpath> (hazard ratio [HR] 5.08 [95% CI 2.06-12.54]) and <z:hpo ids='HP_0000505'>poor visual acuity</z:hpo> (1.74 [1.10-2.75]) remained significantly associated with mortality, after adjusting for other <z:mp ids='MP_0002055'>diabetes</z:mp> complications and baseline characteristics </plain></SENT>
<SENT sid="7" pm="."><plain>In patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, macrovascular disease and worsening levels of <z:hpo ids='HP_0000112'>nephropathy</z:hpo>, <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e>, <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, and visual acuity are associated with progressively increasing risks of mortality, after controlling for other baseline risk factors </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: <z:mpath ids='MPATH_686'>Amputation</z:mpath> is the strongest predictor for mortality in patients with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> complications independently predict mortality in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>There is an increased risk for mortality as the degree of each complication worsens </plain></SENT>
<SENT sid="11" pm="."><plain>Additional studies are needed to investigate the effectiveness of tertiary prevention to decrease mortality in these patients </plain></SENT>
</text></document>